LIFAX PHARMA PRIVATE LIMITED
LIFAX PHARMA PRIVATE LIMITED is a Private Limited Company, incorporated under the Companies Act as a Company limited by Shares. It is classified as Non-govt company and is registered at RoC-Ernakulam.
There are 2 promoter(s) of the company viz.ABDUL NAZZAR, ABDULVAHID ABDULRAHUMAN .
LIFAX PHARMA PRIVATE LIMITED Annual General Meeting (AGM) was last held on as per records from the Ministry of Corporate Affairs (MCA).
Financial Details & Insights
The authorized share capital of the company is Rs.1,00,000 and its paid up capital is Rs.1,00,000. Its balance sheet was last filed on 31-03-2021. LIFAX PHARMA PRIVATE LIMITED Corporate Identification Number (CIN) is U85100KL2019PTC060715 and its registration number is 060715.
Contact Details & Insights
You can contact them by emailing at anazar@life-me.com. The companies registered address is MC XVII /2995 To 3001 District Hospital Road, KOLLAM Kollam KL 691001 IN.
Other Details & Information
LIFAX PHARMA PRIVATE LIMITED's status is Active as per the records. The company is Unlisted.
CIN | U85100KL2019PTC060715 |
Company Name | LIFAX PHARMA PRIVATE LIMITED |
ROC Code | RoC-Ernakulam |
Registration Number | 060715 |
Company Category | Company limited by Shares |
Company SubCategory | Non-govt company |
Class of Company | Private |
Authorised Capital(Rs) | 1,00,000 |
Paid up Capital(Rs) | 1,00,000 |
Number of Members (Applicable in case of company without Share Capital) | 0 |
Date of Incorporation | 11-12-2019 |
Registered Address | MC XVII /2995 To 3001 District Hospital Road, KOLLAM Kollam KL 691001 IN |
Address other than R/o where all or any books of account and papers are maintained | - |
Email Id | anazar@life-me.com |
Whether Listed or not | Unlisted |
Suspended at stock exchange | - |
Date of Last AGM | 30-11-2021 |
Date of Balance Sheet | 31-03-2021 |
Company Status (for efiling) | Active |
Last Updated On | 21-07-2022 |
Directors/Signatory Details
DIN/PAN | Name | Begin Date |
---|---|---|
07694838 | ABDUL NAZZAR | 11-12-2019 |
08636075 | ABDULVAHID ABDULRAHUMAN | 11-12-2019 |